Generic

Glycerol + Hypromellose + Polyethylene Glycol 400

Indications

It is suitable for relieving symptoms of burning, irritation, and discomfort caused by dry eyes or exposure to wind or sunlight. It is also suitable for the treatment of keratoconjunctivitis sicca.

Pharmacology

This eye drops is a transparent, almost colorless, water-based lubricating sterile eye drop that can be dripped into the eyes. After topical use of these eye drops, it will quickly spread on the conjunctiva and cornea, forming a protective and lubricating film. Polyethylene glycol 400 can increase the stability of the tear film, and due to its higher mucosal adhesion properties, hypromellose helps the tear film adhere to the ocular surface. Glycerin restores moisture for dry eyes. Electrolytes similar to natural tears can maintain a good corneal epithelial surface.

Dosage & Administration

1 to 2 drops in the affected eye(s) up to 4 times daily.

Interaction

If multiple medications are to be administered to the eye, at least 5 minutes must elapse between each application.

Contraindications

Patients who are known to be allergic to any component of the product should not use eye drops.

Side Effects

Occasionally, there will be a slight burning or sticky sensation in the short term, and there are few reports of irritation or allergic reactions. Blurred vision may appear after use.

Pregnancy & Lactation

There is no experience regarding the safety of these eye drops during pregnancy or lactation in humans. If pregnant or breastfeeding, please consult a doctor before use.

Precautions & Warnings

Remove contact lenses before using this medicine. Do not use this solution if it changes color or becomes cloudy. Do not touch the tip of the container with any surface to avoid contamination and replace the cap after each use.

Therapeutic Class

Drugs for Dry eyes

Storage Conditions

Store at room temperature. It is desirable that the contents should not be used more than 4 weeks after the first opening of the bottle.

Pharmaceutical Name

Incepta Pharmaceuticals Ltd.